CA1087982A - Fission product of rabies virus, process for its preparation and vaccine containing same - Google Patents

Fission product of rabies virus, process for its preparation and vaccine containing same

Info

Publication number
CA1087982A
CA1087982A CA271,602A CA271602A CA1087982A CA 1087982 A CA1087982 A CA 1087982A CA 271602 A CA271602 A CA 271602A CA 1087982 A CA1087982 A CA 1087982A
Authority
CA
Canada
Prior art keywords
rabies virus
fission product
fraction
preparation
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA271,602A
Other languages
English (en)
French (fr)
Inventor
Lothar G. Schneider
Bernhard Dietzschold
James H. Cox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of CA1087982A publication Critical patent/CA1087982A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/205Rhabdoviridae, e.g. rabies virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA271,602A 1976-02-12 1977-02-11 Fission product of rabies virus, process for its preparation and vaccine containing same Expired CA1087982A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2605469A DE2605469C3 (de) 1976-02-12 1976-02-12 Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff
DEP2605469.3 1976-02-12

Publications (1)

Publication Number Publication Date
CA1087982A true CA1087982A (en) 1980-10-21

Family

ID=5969649

Family Applications (1)

Application Number Title Priority Date Filing Date
CA271,602A Expired CA1087982A (en) 1976-02-12 1977-02-11 Fission product of rabies virus, process for its preparation and vaccine containing same

Country Status (15)

Country Link
JP (1) JPS5299209A (ref)
AT (1) AT350715B (ref)
BE (1) BE851404A (ref)
CA (1) CA1087982A (ref)
CH (1) CH638562A5 (ref)
DE (1) DE2605469C3 (ref)
DK (1) DK145580C (ref)
FR (1) FR2340955A1 (ref)
GB (1) GB1567547A (ref)
IE (1) IE44440B1 (ref)
IL (1) IL51412A (ref)
IT (1) IT1075115B (ref)
LU (1) LU76737A1 (ref)
NL (1) NL7701255A (ref)
OA (1) OA05567A (ref)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070388D1 (en) * 1980-10-02 1985-05-02 Schering Corp Injectable rabies vaccine composition and method for preparing same
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.

Also Published As

Publication number Publication date
DK145580C (da) 1983-05-16
OA05567A (fr) 1981-04-30
ATA92877A (de) 1978-11-15
IT1075115B (it) 1985-04-22
BE851404A (fr) 1977-08-16
CH638562A5 (en) 1983-09-30
DK145580B (da) 1982-12-13
DE2605469A1 (de) 1977-09-15
GB1567547A (en) 1980-05-14
DE2605469C3 (de) 1980-04-10
FR2340955B1 (ref) 1979-03-02
JPS5299209A (en) 1977-08-19
IE44440L (en) 1977-08-12
AT350715B (de) 1979-06-11
DE2605469B2 (de) 1979-08-02
IL51412A0 (en) 1977-04-29
FR2340955A1 (fr) 1977-09-09
DK59377A (da) 1977-08-13
IL51412A (en) 1980-05-30
NL7701255A (nl) 1977-08-16
LU76737A1 (ref) 1977-08-19
IE44440B1 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
Lockart Jr Production of an interferon by L cells infected with Western equine encephalomyelitis virus
MD411C2 (ro) Procedeu de obţinere a pancreatinei din pancreas
Liu et al. Purification and general properties of the lipase of thermophilic fungus Humicola lanuginosa S-38
Diener Isolation of an infectious, ribonuclease-sensitive fraction from tobacco leaves recently inoculated with tobacco mosaic virus
Ida Purification to homogeneity of spinach nitrite reductase by ferredoxin-sepharose affinity chromatography
Boczar et al. A chlorophyll c-containing pigment—protein complex from the marine dinoflagellate, Glenodinium sp.
Apel et al. Chloroplast membranes of the green alga Acetabularia mediterranea. I. Isolation of the photosystem II
Takanami et al. Purification and characterization of the anti-plant viral protein from Mirabilis jalapa L.
Penon et al. Peroxidases associated with lentil root ribosomes
CA1087982A (en) Fission product of rabies virus, process for its preparation and vaccine containing same
Wahlström Purification and characterization of phospholipase A from the venom of Naja nigricollis
Klis et al. Sexual agglutination in the unicellular green alga Chlamydomonas eugametos: Identification and properties of the mating type plus agglutination factor
Galston [140] Plant catalase
Powell et al. Electrophorus acetylcholinesterase: A glycoprotein; molecular weight of its subunits
Riviere et al. Membrane reconstitution in chl-r mutants of Escherichia Coli K 12: VIII. Purification and properties of the FA factor, the product of the chl B gene
De Boer et al. Formation of polynucleate avian erythrocytes by polylysine and phospholipase C
Cox et al. Preparation and characterization of rabies virus hemagglutinin
Dicou et al. Multiple forms of an extracellular cyclic-AMP phosphodiesterase from Dictyostelium discoideum
Chen et al. Properties of the membrane-bound Mg2+-ATPase isolated from Acholeplasma laidlawii
Pullan et al. Purification and properties of pig muscle carbonic anhydrase III
Naidu et al. Studies on peanut green mosaic virus infected peanut (Arachis hypogaea L.) leaves. III. Changes in the polypeptides of photosystem II particles
Schwenker et al. A carotenoprotein from chromatophores of Rhodospirillum rubrum
Pang et al. Cardiac sarcolemma of the hamster. Enrichment of the (Na++ K+)-ATPase
Hashimoto et al. Isolation of the structural proteins of western equine encephalitis virus by isoelectric focusing
EP0114342B1 (en) A method of producing reverse transcriptase

Legal Events

Date Code Title Description
MKEX Expiry